A novel TLR7 agonist as adjuvant to stimulate high quality ...
T7-EA might be a candidate adjuvant in a prophylactic and therapeutic HBV vaccine. A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model J Transl Med. 2020 Mar 4;18(1):112. doi: 10.1186/s12967-020-02275-2. ...
Get Price